医薬品ADMET試験の世界市場レポート 2024年

医薬品ADMET試験の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.5%の年間複合成長率（CAGR）で148億7,000万米ドルに成長すると予想されます。予測期間の予想拡大は、環境毒物学と安全性評価の重視の高まり、薬理ゲノミクスへの意識の高まり、精密医療への戦略的焦点、生物製剤とバイオシミラーの普及の拡大、人工知能（AI）の統合などの要因によるものと考えられます。規制要件の強化、希少疾病用医薬品の開発の増加。予測期間中に予想される注目すべき動向には、共同調査活動の増加、急速な技術革新、分析技術の進歩、医薬品の安全性監視における継続的な警戒、環境への影響への配慮の高まりなどが含まれます。

製品承認の増加傾向は、医薬品ADMET試験市場の主要な推進力です。製品の承認には、米国の食品医薬品局（FDA）や欧州の欧州医薬品庁（EMA）などの当局による規制上の承認が含まれ、製品の一般販売が許可されます。 ADMETテストは新製品の安全性と有効性を評価する上で重要な役割を果たしており、規制当局の承認プロセスに含めることが義務付けられています。特に、医薬品評価研究センターは、2020年に米国で53の医薬品が承認されたと報告しており、2019年に承認された48の医薬品から増加していることを示しています。その結果、製品承認数の増加が医薬品ADMET試験市場の促進剤として機能します。

臨床試験の急増は、将来の医薬品ADMET試験市場の成長を促進すると予想されます。臨床試験は、人間の参加者を対象とした重要な調査であり、新薬、医療機器、診断手順、治療計画などの医療介入の安全性、有効性、潜在的な副作用を評価します。臨床試験の数が増加しているため、医薬品ADMET試験市場内での医薬品の安全性と有効性の包括的な評価に対する需要が大幅に高まっています。たとえば、Xtalksのレポートによると、2023年 5月の時点で、ClinicalTrials.govには45万2,604件の臨床研究が登録されており、2021年初頭に記録された36万5,000件を超える臨床試験から顕著に増加していることがわかります。この増加は、カスタマイズ型評価に対する業界のニーズの高まりを浮き彫りにしています。これにより、医薬品ADMET試験市場の拡大が推進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の医薬品ADMET試験市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の医薬品ADMET試験が市場規模実績と成長率をテスト（2018～2023年）
• 世界の医薬品ADMET試験市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の医薬品ADMET試験市場、試験タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• In Vivo
• In Vitro
• In Silico
• 世界の医薬品ADMET試験市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 細胞培養
• 高スループット
• 分子イメージング
• OMICS技術
• 世界の医薬品ADMET試験市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 全身毒性
• 腎毒性
• 肝毒性
• 神経毒性
• その他

第7章 地域と国の分析

• 世界の医薬品ADMET試験市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の医薬品ADMET試験市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品ADMET試験市場の競合情勢
• 医薬品ADMET試験市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • The Merck Group
  • Laboratory Corporation of America Holdings
  • IQVIA Inc.

第31章 その他の大手と革新的な企業

• PPD ICON plc
• Agilent Technologies Inc.
• Wuxi AppTec Co. Ltd.
• Catalent Inc.
• Covance Inc.
• Charles River Laboratories International Inc.
• Eurofins Scientific SE
• Beckman Coulter Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Albany Molecular Research Inc.
• Evotec AG
• CMIC Holdings Co. Ltd.
• Promega Corporation
• Aptuit LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Pharmaceutical ADMET testing encompasses a series of methodologies and assays employed in the pharmaceutical sector to evaluate the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) characteristics of drug candidates. This essential process is instrumental in gauging the safety and effectiveness of prospective drugs prior to obtaining regulatory approval for clinical application.

The primary categories of pharma ADMET testing include in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In vivo ADMET testing involves the analysis of a drug's absorption, distribution, metabolism, excretion, and toxicity attributes within a living organism. Widely utilized throughout drug discovery and development phases, pharma ADMET testing plays a crucial role in pinpointing potential drug candidates endowed with favorable pharmacokinetic properties. Utilizing advanced technologies such as cell culture, high throughput, molecular imaging, and OMICS, pharma ADMET testing is pivotal in assessing systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other relevant parameters. This comprehensive approach aids in the strategic identification of drug candidates that align with desired efficacy and safety profiles, thereby contributing to informed decision-making in the pharmaceutical business landscape.

The pharma ADMET testing market research report is one of a series of new reports from The Business Research Company that provides pharma ADMET testing market statistics, including the pharma ADMET testing industry's global market size, regional shares, competitors with a pharma ADMET testing market share, detailed pharma ADMET testing market segments, market trends, and opportunities, and any further data you may need to thrive in the pharma ADMET testing industry. This pharma ADMET testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharma admet testing market size has grown rapidly in recent years. It will grow from $8.62 billion in 2023 to $9.61 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%.The expansion observed in the historical period can be ascribed to the increasing prominence of biopharmaceuticals and biosimilars, a surge in drug development initiatives, heightened awareness concerning drug safety, the globalization of clinical trials, and a notable shift towards in silico modeling.

The pharma admet testing market size is expected to see rapid growth in the next few years. It will grow to $14.87 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The anticipated expansion in the forecast period can be credited to factors such as increased emphasis on environmental toxicology and safety assessment, heightened awareness of pharmacogenomics, a strategic focus on precision medicine, the growing prevalence of biologics and biosimilars, the integration of artificial intelligence (AI), heightened regulatory requirements, and an upswing in orphan drug development. Notable trends expected in the forecast period encompass a rise in collaborative research efforts, rapid technological innovations, advancements in analytical technologies, ongoing vigilance in drug safety monitoring, and a heightened consideration of environmental impacts.

The upward trend in product approvals is a key driver for the pharma ADMET testing market. Product approvals involve the regulatory endorsement by authorities such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, allowing products to be marketed to the public. ADMET testing plays a crucial role in assessing the safety and efficacy of new products, and its inclusion is mandatory in the regulatory approval process. Notably, the Center for Drug Evaluation and Research reported that in 2020, 53 drugs received approval in the United States, indicating an increase from the 48 drugs approved in 2019. Consequently, the growing number of product approvals serves as a catalyst for the pharma ADMET testing market.

The surge in clinical trials is expected to drive the pharma ADMET testing market's growth in the future. Clinical trials, essential research studies involving human participants, evaluate the safety, efficacy, and potential side effects of medical interventions, including new drugs, medical devices, diagnostic procedures, or treatment regimens. The escalating number of clinical trials significantly amplifies the demand for comprehensive assessments of drug safety and efficacy within the pharma ADMET testing market. For example, a report from Xtalks reveals that, as of May 2023, there are 452,604 registered clinical studies on ClinicalTrials.gov, indicating a notable increase from the over 365,000 trials recorded in early 2021. This uptick underscores the industry's growing need for tailored evaluations across diverse drug candidates and patient populations, thereby propelling the pharma ADMET testing market's expansion.

A prominent trend gaining traction in the pharma ADMET testing market is the focus on product innovations, with major companies introducing cutting-edge solutions to enhance their market position. Notably, Charles River Laboratories International Inc. and Valo Health Inc. launched Logica in April 2022-an AI-based drug development solution. Leveraging Valo's Opal Computational Platform, Logica provides users with ADMET testing services and other drug delivery solutions. The solution incorporates industry-leading predictive models, chemical design and synthesis capabilities, DNA-encoded libraries, and in silico high-throughput screening. Charles River's expertise in various discovery optimization aspects, including high-throughput screening, medicinal chemistry, ADME, biology, pharmacology, safety testing, and IND submission, further enhances Logica's capabilities.

Major players in the pharma ADMET testing market are strategically engaging in partnerships to advance efforts in discovering allosteric drugs. An illustrative example is the collaboration between Excelra and HotSpot Therapeutics Inc. In May 2022, Excelra, specializing in accelerating drug discovery through advanced data science, partnered with HotSpot Therapeutics Inc., a biotechnology company focused on small molecule allosteric therapies. This strategic alliance involves integrating Excelra's product, GOSTAR, and its annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models. GOSTAR, with insights into over 8 million small molecules, provides comprehensive information on chemical structures and various biological properties, facilitating the exploration and development of small molecule therapeutic candidates targeting challenging allosteric sites.

In September 2022, BioIVT, a prominent drug development solutions provider based in the United States, successfully completed the acquisition of XenoTech for an undisclosed sum. This strategic move is designed to enhance BioIVT's product portfolio by integrating XenoTech's capabilities and to facilitate the expansion of its product offerings into new geographic regions, thereby reaching a broader customer base. XenoTech, a respected US-based contract research organization, specializes in offering ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) testing services. This acquisition underscores BioIVT's commitment to strengthening its position in the drug development sector by incorporating complementary expertise and extending its reach to cater to evolving market demands.

Major companies operating in the pharma admet testing market report are Thermo Fisher Scientific Inc., Abbott Laboratories, The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON PLC, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Bio-Rad Laboratories Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Asia-Pacific was the largest region in the pharma ADMET testing market in 2023. The regions covered in the pharma admet testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma admet testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma ADMET testing market consists of revenues earned by entities by providing services such as in vitro screening, in vitro metabolism, and metabolite testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma ADMET testing market also includes the sales of membranes, buffer systems, and analytes that are used in the assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma ADMET Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma admet testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma admet testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma admet testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing
• 2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology
• 3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; The Merck Group; Laboratory Corporation of America Holdings; IQVIA Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma ADMET Testing Market Characteristics

3. Pharma ADMET Testing Market Trends And Strategies

4. Pharma ADMET Testing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pharma ADMET Testing Market Size and Growth

• 5.1. Global Pharma ADMET Testing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pharma ADMET Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pharma ADMET Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharma ADMET Testing Market Segmentation

• 6.1. Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• In Vivo ADMET Testing
• In Vitro ADMET Testing
• In Silico ADMET Testing
• 6.2. Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology
• 6.3. Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Applications

7. Pharma ADMET Testing Market Regional And Country Analysis

• 7.1. Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharma ADMET Testing Market

• 8.1. Asia-Pacific Pharma ADMET Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharma ADMET Testing Market

• 9.1. China Pharma ADMET Testing Market Overview
• 9.2. China Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharma ADMET Testing Market

• 10.1. India Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharma ADMET Testing Market

• 11.1. Japan Pharma ADMET Testing Market Overview
• 11.2. Japan Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharma ADMET Testing Market

• 12.1. Australia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharma ADMET Testing Market

• 13.1. Indonesia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharma ADMET Testing Market

• 14.1. South Korea Pharma ADMET Testing Market Overview
• 14.2. South Korea Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharma ADMET Testing Market

• 15.1. Western Europe Pharma ADMET Testing Market Overview
• 15.2. Western Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharma ADMET Testing Market

• 16.1. UK Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharma ADMET Testing Market

• 17.1. Germany Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharma ADMET Testing Market

• 18.1. France Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharma ADMET Testing Market

• 19.1. Italy Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharma ADMET Testing Market

• 20.1. Spain Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharma ADMET Testing Market

• 21.1. Eastern Europe Pharma ADMET Testing Market Overview
• 21.2. Eastern Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharma ADMET Testing Market

• 22.1. Russia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharma ADMET Testing Market

• 23.1. North America Pharma ADMET Testing Market Overview
• 23.2. North America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharma ADMET Testing Market

• 24.1. USA Pharma ADMET Testing Market Overview
• 24.2. USA Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharma ADMET Testing Market

• 25.1. Canada Pharma ADMET Testing Market Overview
• 25.2. Canada Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharma ADMET Testing Market

• 26.1. South America Pharma ADMET Testing Market Overview
• 26.2. South America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharma ADMET Testing Market

• 27.1. Brazil Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharma ADMET Testing Market

• 28.1. Middle East Pharma ADMET Testing Market Overview
• 28.2. Middle East Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharma ADMET Testing Market

• 29.1. Africa Pharma ADMET Testing Market Overview
• 29.2. Africa Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles

• 30.1. Pharma ADMET Testing Market Competitive Landscape
• 30.2. Pharma ADMET Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. The Merck Group
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Laboratory Corporation of America Holdings
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. IQVIA Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pharma ADMET Testing Market Other Major And Innovative Companies

• 31.1. PPD ICON plc
• 31.2. Agilent Technologies Inc.
• 31.3. Wuxi AppTec Co. Ltd.
• 31.4. Catalent Inc.
• 31.5. Covance Inc.
• 31.6. Charles River Laboratories International Inc.
• 31.7. Eurofins Scientific SE
• 31.8. Beckman Coulter Inc.
• 31.9. PerkinElmer Inc.
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Albany Molecular Research Inc.
• 31.12. Evotec A.G.
• 31.13. CMIC Holdings Co. Ltd.
• 31.14. Promega Corporation
• 31.15. Aptuit LLC

32. Global Pharma ADMET Testing Market Competitive Benchmarking

33. Global Pharma ADMET Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

35. Pharma ADMET Testing Market Future Outlook and Potential Analysis

• 35.1 Pharma ADMET Testing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pharma ADMET Testing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pharma ADMET Testing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer